hotspot -WSS

hotspot

author：leisure time 2025-09-30 07:38:48 - browse：5

Adam's take main illustration — Molly Ferguson/STAT

The approval Friday of Bluebird Bio’s gene therapy for sickle cell disease should have been a momentum-swinging achievement for the long-struggling biotech. Instead, the company mispriced its new drug and fumbled a pivotal financial lifeline.

The consequences of these strategic blunders — arguably, self-inflicted — could imperil Bluebird’s independence, perhaps even its survival.

Bluebird priced Lyfgenia at $3.1 million, while Vertex Pharmaceutical set the cost of Casgevy, its competing sickle cell treatment also approved on Friday, at $2.2 million. Not only is Lyfgenia significantly more expensive, but its prescribing label carries a “black box” safety warning, which requires patients undergo regular blood monitoring for cancer risk. Casgevy has no similar monitoring requirement.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Tori Bowie and the unacceptable rates of Black maternal death
Next article： UnitedHealth’s Optum accused of antitrust violations in California

WSS

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

Adele warns fans about throwing things at performers onstage

Man pleads guilty to raping Ohio girl who ended up traveling across state lines for abortion

Man pleads guilty to raping Ohio girl who ended up traveling across state lines for abortion

Accuser says Kevin Spacey grope wasn't a caress: ‘It was like a cobra ... angry’

EU moves toward latest gene techniques in food production to counter climate change, shortages

explore

hotspot

focus

Drug repurposing or repositioning? The language matters

CDC director unscathed in first congressional testimony

Moonlake's readout produced a cash windfall. Risks remain

What to do when lifesaving products contribute to climate change

At least 13 dead in Texas as scorching temps continue

U.K. Biobank has 500,000 peoples' genome sequences available

Hepatitis C has a cure — but many Americans still lack access to it

1 in 4 Americans hadn't contracted COVID by the end of 2022, CDC estimates

After affirmative action ruling, medical educators look to 'holistic review'

'Insanity': 4th of July mass shootings across US kill 13, injure more than 80

Wikipedia

What don’t we know about an Alzheimer’s drug side effect?

2 million sign

Search warrant issued in 1996 disappearance of Kristin Smart

Former New York Mayor de Blasio and wife announce separation, but not divorce

U.K. Biobank has 500,000 peoples' genome sequences available

What to do when lifesaving products contribute to climate change

focus

entertainment

leisure time

entertainment